Nakayama M, Brandenburg J H
Department of Surgery, University of Wisconsin, Madison.
Arch Otolaryngol Head Neck Surg. 1993 Sep;119(9):950-7. doi: 10.1001/archotol.1993.01880210038006.
To evaluate the accuracy of clinical staging of advanced laryngeal cancer and to morphologically analyze the underestimated cases.
We conducted a retrospective histopathologic study of larynges from patients who had had total laryngectomy and were seen over a 21-year period.
Academic tertiary referral medical center.
Forty-one patients had clinically staged T3 laryngeal cancer and 16 patients had T4 cancer.
Patients all underwent wide-field total laryngectomy. All larynges were processed as whole-organ serial sections in the coronal plane.
The incidence of clinically underestimated laryngeal cancer. During this investigation, it became obvious that predictive indicators of thyroid cartilage involvement could be established.
Clinical underestimation had been made in approximately 50% of all T3 laryngeal cancer cases. The extent of the cartilage involvement in the underestimated group was characterized by microinvasion without penetration; approximately 90% of the cartilage involvement affected the thyroid notch and adjacent area. We established five objective indicators of thyroid cartilage involvement: (1) extensive cartilage ossification (risk for cartilage involvement, 73%); (2) glottic fixation (54%); (3) transglottic cancer (74%); (4) tumor length longer than the entire vocal fold length or longer than 2 cm (66%); and (5) extensive involvement of the anterior commissure (67%).
Clinical underestimation of T4 laryngeal cancer was high because thyroid cartilage involvement was not accurately diagnosed. We believe our indicators of thyroid cartilage involvement will provide objective guidelines for laryngeal cancer staging and will contribute to more reliable clinical cancer-staging decisions.
评估晚期喉癌临床分期的准确性,并对分期低估的病例进行形态学分析。
我们对21年间接受全喉切除术患者的喉部进行了回顾性组织病理学研究。
学术性三级转诊医疗中心。
41例患者临床分期为T3喉癌,16例患者为T4癌。
所有患者均接受了广域全喉切除术。所有喉部均制成冠状面全器官连续切片。
喉癌临床分期低估的发生率。在本研究过程中,很明显可以建立甲状软骨受累的预测指标。
所有T3喉癌病例中约50%存在临床分期低估。分期低估组软骨受累程度的特征为微侵袭但未穿透;约90%的软骨受累影响甲状软骨切迹及相邻区域。我们建立了甲状软骨受累的五个客观指标:(1)广泛软骨骨化(软骨受累风险为73%);(2)声门固定(54%);(3)跨声门癌(74%);(4)肿瘤长度超过整个声带长度或超过2 cm(66%);(5)前联合广泛受累(67%)。
T4喉癌临床分期低估率较高,因为甲状软骨受累未得到准确诊断。我们认为我们的甲状软骨受累指标将为喉癌分期提供客观指导,并有助于做出更可靠的临床癌症分期决策。